We're not even 11 days into Skin Cancer Awareness Month, and already my awareness about the disease has been raised several times.
Think about this:
Researchers involved in a large skin cancer trial measured 2,3,5-pyrroletricarboxylic acid (PTCA) levels of 98 subjects with melanoma and 98 subjects without melanoma. They found the subjects with a PTCA concentration below 85ng/mg had more than four times the risk of developing melanoma.
